Fresenius SE & Co KGaA
XETRA:FRE

Watchlist Manager
Fresenius SE & Co KGaA Logo
Fresenius SE & Co KGaA
XETRA:FRE
Watchlist
Price: 33.34 EUR -0.33%
Market Cap: 18.8B EUR
Have any thoughts about
Fresenius SE & Co KGaA?
Write Note
Section:
 

Relative Value

The Relative Value of one FRE stock under the Base Case scenario is 49.2 EUR. Compared to the current market price of 33.34 EUR, Fresenius SE & Co KGaA is Undervalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FRE Relative Value
Base Case
49.2 EUR
Undervaluation 32%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
3
vs Industry
76
Median 3Y
0.5
Median 5Y
0.5
Industry
2.3
Forward
0.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
24
Median 3Y
9.3
Median 5Y
10.6
Industry
23.1
Forward
11.6
More Details
6.1
P/OCF
P/OCF
Price to OCF
6.1
vs History
3
vs Industry
48
Median 3Y
3.6
Median 5Y
3.6
Industry
14.2
More Details
71.5
P/FCFE
P/FCFE
Price to FCFE
71.5
vs History
3
vs Industry
36
Median 3Y
12
Median 5Y
10.7
Industry
20.1
More Details
1
P/B
P/B
Price to Book Value
1
vs History
41
vs Industry
67
Median 3Y
0.8
Median 5Y
1
Industry
2.2
More Details
1.3
EV/S
EV/S
Enterprise Value to Sales
1.3
vs History
17
vs Industry
67
Median 3Y
1.1
Median 5Y
1.1
Industry
2.4
Forward
1.2
More Details
5.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.2
vs History
12
vs Industry
46
Median 3Y
4
Median 5Y
4
Industry
5
More Details
9.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.3
vs History
17
vs Industry
32
Median 3Y
6.3
Median 5Y
6.1
Industry
12.7
Forward
7.6
More Details
18.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.9
vs History
17
vs Industry
26
Median 3Y
11.3
Median 5Y
10.4
Industry
17.1
Forward
11.6
More Details
8.8
EV/OCF
EV/OCF
Enterprise Value to OCF
8.8
vs History
39
vs Industry
43
Median 3Y
8.6
Median 5Y
8.5
Industry
14
More Details
12.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
12.8
vs History
58
vs Industry
34
Median 3Y
14.4
Median 5Y
14.4
Industry
18
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
3
vs Industry
69
Median 3Y
0.6
Median 5Y
0.6
Industry
1.9
More Details

Multiples Across Competitors

FRE Competitors Multiples
Fresenius SE & Co KGaA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49 9.3 18.9
US
Cigna Corp
NYSE:CI
78.7B USD 0.3 25.9 8.1 10.4
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.8B EUR 1.3 48.1 11.2 25.8
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.4 13.2 20.5
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.5 12.3 16.7
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.8B EUR 0.7 24.1 7 16.3
US
DaVita Inc
NYSE:DVA
12.9B USD 1 15.5 8 11.2
AU
Sonic Healthcare Ltd
ASX:SHL
13.1B AUD 1.5 25.6 19.2 19.2
P/E Multiple
Earnings Growth PEG
DE
Fresenius SE & Co KGaA
XETRA:FRE
Average P/E: 26.8
Negative Multiple: -49 		N/A N/A
US
Cigna Corp
NYSE:CI
25.9
25%
1
US
C
Cigna Group
XMUN:CGN
25.9
25%
1
US
CVS Health Corp
NYSE:CVS
11.3
3%
3.8
DE
Fresenius Medical Care AG
XMUN:FME
48.1
31%
1.6
US
Laboratory Corporation of America Holdings
NYSE:LH
44.4
54%
0.8
US
Quest Diagnostics Inc
NYSE:DGX
20.5
12%
1.7
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
253%
N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.1
31%
0.8
US
DaVita Inc
NYSE:DVA
15.5
17%
0.9
AU
Sonic Healthcare Ltd
ASX:SHL
25.6
11%
2.3

See Also

Summary
FRE intrinsic value, competitors valuation, and company profile.
DCF Valuation
FRE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FRE stock valuation using valuation multiples.
Wall Street Estimates
FRE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FRE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.